Skip to main content

Table 2 The comparison of blood glucose indexes in two groups before and after intervention

From: Effects of cinnamon supplementation on expression of systemic inflammation factors, NF-kB and Sirtuin-1 (SIRT1) in type 2 diabetes: a randomized, double blind, and controlled clinical trial

Variables

Cinnamon Group, n = 20

Placebo Group, n = 19

P**

Before Treatment

 FBS (mg/dL)

183.85 ± 36.16

190.57 ± 70.58

0.71

 FI (mU/L)

9.85 (7.92–19.22)

10.60 (8.80–17.30)

0.86

 HgA1c

10.04 ± 1.30

10.31 ± 1.86

0.59

 HOMA-IR

5.35 (2.97–9.22)

5.39 (2.64–6.98)

0.86

After Treatment

 FBS (mg/dL)

172.20 ± 44.86

199.15 ± 49.86

0.53

 Differences

11.65 ± 29.34

8.57 ± 35.10

0.06

P*

0.09

0.30

 

 FI (mU/L)

12.10 (10.65–18.45)

12.20 (9.30–14.20)

0.73

 Differences

2.05 (−1.62–5.45)

1.20 (−2.40–4.70)

0.86

P*

0.24

0.46

 

 HgA1c

10.11 ± 1.49

10.30 ± 1.70

0.86

 Differences

0.075 ± 1.51

0.15 ± 1.93

0.87

P*

0.83

0.97

 

 HOMA-IR

6.00 (3.34–9.00)

6.16 (3.48–8.49)

0.83

 Differences

0.03 (1.50–1.97)

0.68 (0.73–1.50)

0.42

P*

1.00

0.39

 
  1. Data are presented as mean ± standard deviation (SD) or median (25–75 interquartile range) for continuous variables. * P was applied for the comparisons among groups, with the use of Student’s t-test for continuous variables, Mann–Whitney test for variables with non-normal distribution. ** P was used for the comparisons between groups, with use of paired t-test for continuous variables, Wilcoxon test for variables with non-normal distribution. Difference is significant at P < 0.050. Abbreviations: FBS Fasting Blood Sugar, FI Fasting Insulin, HgA1c HemoglobinA1c, HOMA-IR Homeostasis model assessment for insulin resistance